Elinor Willis
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune Response and Inflammation 2
-
- Viral Infections and Vectors 2
- Parasitic Diseases Research and Treatment 2
- Co-authors
- Scott E. Hensley (3 shared papers)Kaela Parkhouse (2 shared papers)Drew Weissman (1 shared paper)Norbert Pardi (1 shared paper)Barbara L. Mui (1 shared paper)Ying K. Tam (1 shared paper)Sandip Chatterjee (1 shared paper)Enrico Radaelli (6 shared papers)
- Journals
- Veterinary Pathology (4 papers)Nature (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)Vaccine (1 paper)Blood (1 paper)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Elinor Willis
16 papers receiving 1.2k citations
Elinor Willis's Hit Papers
Peers
Comparison fields: 5 of 75
- Infectious Diseases 605
- Immunology 362
- Virology 58
- Animal Science and Zoology 114
- Public Health, Environmental and Occupational Health 250
Countries citing papers authored by Elinor Willis
This map shows the geographic impact of Elinor Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elinor Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elinor Willis more than expected).
Fields of papers citing papers by Elinor Willis
This network shows the impact of papers produced by Elinor Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elinor Willis. The network helps show where Elinor Willis may publish in the future.
Co-authors
The 25 scholars most cited alongside Elinor Willis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Hit paper breakdown → | 2017 | 738 |
| 2 | 2018 | 429 | |
| 3 | 2020 | 43 | |
| 4 | 2017 | 17 | |
| 5 | 2014 | 13 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 1993 | 6 | |
| 10 | 2025 | 4 | |
| 11 | 2022 | 2 | |
| 12 | Proceedings: Studies on carriers of Australia antibody. | 1974 | 2 |
| 13 | 2025 | 2 | |
| 14 | 2026 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2024 | 0 |
About Elinor Willis
Elinor Willis is a scholar working on Immunology, Infectious Diseases, Epidemiology, Genetics and Otorhinolaryngology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Viral Infections and Vectors (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Influenza Virus Research Studies (2 papers), Mosquito-borne diseases and control (2 papers), Parasitic Diseases Research and Treatment (2 papers), Virus-based gene therapy research (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Infectious Diseases (605 citations), Immunology (362 citations), Virology (58 citations), Animal Science and Zoology (114 citations) and Public Health, Environmental and Occupational Health (250 citations). Elinor Willis has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Scott E. Hensley, Kaela Parkhouse, Drew Weissman, Norbert Pardi, Barbara L. Mui, Ying K. Tam, Sandip Chatterjee, Enrico Radaelli, Girish Deshpande and Paul D. Schedl. Their work appears in journals such as Veterinary Pathology, Nature, Molecular Therapy — Methods & Clinical Development, Vaccine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.